$83.94
Ipamorelin
What is Ipamorelin?
Ipamorelin Structure

- Ipamorelin
- 170851-70-4
- Ipamorelin [INN]
- NNC-26-0161
- UNII-Y9M3S784Z6
- Y9M3S784Z6
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
- NNC-260161
- IPAMORELIN [WHO-DD]
- NNC 26-0161
- Aib-His-2Nal-Phe-Lys-NH2
- 2-Methylalanyl-L-histidyl-3-(2-naphthyl)-D-alanyl-D-phenylalanyl-L-lysinamide
- (2S)-6-amino-2-((2R)-2-((2R)-2-((2S)-2-(2-amino-2-methylpropanamido)-3-(1H-imidazol-4-yl)propanamido)-3-(naphthalen-2-yl)propanamido)-3-phenylpropanamido)hexanamide
- (2S)-6-amino-2-[(2R)-2-[(2R)-2-[(2S)-2-(2-amino-2-methylpropanamido)-3-(1H-imidazol-4-yl)propanamido]-3-(naphthalen-2-yl)propanamido]-3-phenylpropanamido]hexanamide
- DTXCID9091446
- dtxsid80168955
- IPAMORELIN ACETATE
- Ipamorelina
Research Applications:
Research Links:
-
Raun, K., et al. (1998). “Ipamorelin, the first selective growth hormone secretagogue.” European Journal of Endocrinology, 139(5), 552-561. https://pubmed.ncbi.nlm.nih.gov/9845453/
-
Introduces Ipamorelin’s selective GH-releasing properties, relevant to muscle growth and metabolic research.
-
-
Sinha, D. K., et al. (2018). “Beyond the androgen receptor: The role of growth hormone secretagogues in the modern management of body composition in men.” Translational Andrology and Urology, 7(Suppl 4), S476-S482. https://pubmed.ncbi.nlm.nih.gov/30333897/
-
Discusses growth hormone secretagogues like Ipamorelin in body composition and muscle recovery studies.
-
-
Andersen, N. B., et al. (2001). “Growth hormone secretagogues: Recent advances and applications.” Drug Discovery Today, 6(20), 1053-1058. https://pubmed.ncbi.nlm.nih.gov/11595155/
-
Explores the role of secretagogues, including Ipamorelin, in muscle growth and metabolic regulation.
-
-
Gobbi, S., et al. (2014). “Growth hormone secretagogues and their potential in muscle repair and recovery.” Journal of Muscle Research and Cell Motility, 35(1), 1-8. https://pubmed.ncbi.nlm.nih.gov/24557831/
-
Examines Ipamorelin’s effects on muscle repair and recovery in preclinical models.
-
-
Lall, S., et al. (2001). “Growth hormone releasing peptides: Focus on therapeutic potential in muscle wasting.” Current Opinion in Clinical Nutrition & Metabolic Care, 4(3), 183-187. https://pubmed.ncbi.nlm.nih.gov/11464982/
-
Reviews the role of peptides like Ipamorelin in muscle wasting prevention and recovery.
-
| CAS |
170851-70-4 |
|---|---|
| PubChem CID |
9831659 |
| Molecular Weight |
711.85 g/mol |
| Amino Acid Sequence |
Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| PubChem Link | |
| Product Note |
For laboratory use only. Not for human or veterinary use. Proper handling and storage (-20°C) are required to maintain stability. Ensure compliance with all applicable regulations when conducting research with this compound. Peptides will arrive in a lyophilized (powder) form for maximum stability. |
